tiprankstipranks
Trending News
More News >

Grand Pharmaceutical Clarifies Bye-Laws Document Headline Error

Story Highlights

An announcement from Grand Pharmaceutical Group Limited ( (HK:0512) ) is now available.

Grand Pharmaceutical Group Limited issued a clarification regarding an operational mistake in the headline of its Bye-Laws document. The headline was incorrectly labeled as ‘Documents on Display’ instead of ‘Constitutional Documents’. The company has corrected this error by re-uploading the document with the correct headline, ensuring that the content of the Bye-Laws remains unchanged.

More about Grand Pharmaceutical Group Limited

Grand Pharmaceutical Group Limited is a company incorporated in Bermuda, operating within the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products, with a market presence highlighted by its listing on the Hong Kong Stock Exchange.

YTD Price Performance: 27.29%

Average Trading Volume: 5,721,817

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$21.44B

For detailed information about 0512 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App